Clinical findings in recent decades have provided detailed information for reference in model formulations including high insulin-induced insulin resistance, reduced insulin clearance, the coexistence of positive and negative effects of FFAs on beta-cell function, and so on. The gene discussed is INS; the disease is Insulin resistance.